Related Experiment Video
Updated: Jun 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal infections in high-risk and immunocompromised hosts
Olarn Prommalikit1, Krisana Pengsaa, Usa Thisyakorn
1Department of Pediatrics, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand. drolarnp2002@yahoo.com
Streptococcus pneumoniae causes significant global disease, particularly invasive pneumococcal disease (IPD). Understanding risk factors like immunocompromised status is key to preventing infections in vulnerable populations.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Streptococcus pneumoniae is a major global pathogen causing significant morbidity and mortality.
- It is responsible for invasive pneumococcal disease (IPD) and non-IPD, with high incidence in young children, the elderly, and immunocompromised individuals.
- Nasopharyngeal colonization precedes IPD, highlighting the importance of understanding host-pathogen interactions.
Purpose of the Study:
- To describe the factors contributing to the development of invasive pneumococcal disease.
- To elucidate the role of host immunity, genetics, and environmental factors in pneumococcal infections.
- To detail immunocompromising conditions predisposing individuals to pneumococcal disease.
Main Methods:
- Review of existing literature on Streptococcus pneumoniae epidemiology and pathogenesis.
- Analysis of host-related factors, including immune status, age, and genetic predispositions.
- Identification of specific immune defects and conditions associated with increased IPD risk.
Main Results:
- Invasive pneumococcal disease development is influenced by a combination of host immunity (innate and specific), genetic, and environmental factors.
- Specific host responses to pneumococcal infections can be compromised by factors such as young age, antibody deficiencies, complement factor deficiencies, and splenic dysfunction.
- Immunocompromised hosts and individuals with specific underlying medical conditions exhibit higher rates of IPD.
Conclusions:
- Understanding the complex interplay of host factors is crucial for preventing and managing Streptococcus pneumoniae infections.
- Identifying and addressing specific immune defects can mitigate the risk of invasive pneumococcal disease.
- Further research into host-pathogen dynamics in immunocompromised populations is warranted.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology